Related Experiment Video
Updated: Jun 19, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
Evaluation criteria for pharmacoeconomic and health economic Internet resources
1University of the Sciences in Philadelphia, 600 South 43rd Street, Philadelphia, PA 19104, USA. w.mcghan@usip.edu
Abstract:
The purpose of this paper is to present criteria for evaluating Internet sites and supply a selective sample of sites that may be useful in improving the transfer of information and diffusion of innovation in pharmacoeconomics and health economics. The nine criteria deal with the following: 1) Expertise - Qualified individuals should generate the information. 2) Confidentiality - All patient data should be confidential and protected. 3) Referencing - Information should be supported with proper citations. 4) Justification - Rigorous evidence should support the claims relating to benefits, risks and costs of any intervention or service. 5) Authorship - provided in the clearest manner with contact addresses. 6) Sponsorship - Support for sites should be clearly identified. 7) Advertising & Editorial Policy - Advertising should be distinguishable from other informational content. 8) Study Evaluation - should comply with the standard economic evaluation checklists 9) Generalizability - Sites should define their target countries and audiences and discuss potential generalizability.
Related Concept Videos
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Analysis of Population Pharmacokinetic Data
Dosage Regimens: Partial Pharmacokinetic Parameters
Health Information Technology and Healthcare Information System
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include:
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Measurement of Bioavailability: Pharmacodynamic Methods